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Abstract
Background: Current clinical protocols for MR-guided focused ultrasound (MRgFUS) treatment of osseous lesions,
including painful bone metastases and osteoid osteomas, rely on measurement of the temperature change in
adjacent muscle to estimate the temperature of the bone. The goal of this study was to determine if T2-based
thermometry could be used to monitor the temperature change in bone marrow during focused ultrasound
ablation of bone lesions.
Methods: We investigated the dependence of T2 on temperature in ex vivo bovine yellow bone marrow at 3T and
studied the influence of acquisition parameters on the T2 measurements. We examined if T2 changes in red bone
marrow caused by the ablation of ex vivo trabecular bone were reversible and measured the patterns of heating
and tissue damage. The technique was validated during the ablation of intact ex vivo bone samples and an in vivo
animal model.
Results: Results of the calibration experiment showed a linear relationship (7 ms/°C) between T2 change and
temperature and could be used to quantify the temperature during heating of up to 60 °C. During trabecular bone
ablation, we observed a linear relationship (5.7 ms per °C) between T2 and temperature during the heating stage of
the experiment. After cool down, there was residual T2 elevation (~35 ms) in the ablated area suggesting
irreversible tissue changes.
In ex vivo and in vivo cortical bone ablation experiments, we observed an increase in T2 values in the marrow
adjacent to the intersection of the cortical bone and the beam path. The in vivo experiment showed excellent
correspondence between the area of T2 elevation in marrow during the ablation and the resulting non-enhancing
area in the post-contrast images.
Conclusions: In this study, we have demonstrated that T2-based thermometry can be used in vivo to measure the
heating in the marrow during bone ablation. The ability to monitor the temperature within the bone marrow
allowed more complete visualization of the heat distribution into the bone, which is important for local lesion
control.
Keywords: MR-guided focused ultrasound, HIFU, MR thermometry, T2 mapping, Bone marrow
Background
MR-guided focused ultrasound (MRgFUS) is a noninva-
sive ablation technique that has grown tremendously
over the past years for a broad array of applications such
as treatment of uterine fibroids [1], painful bone metas-
tases [2], breast cancer [3], and hepatocellular carcinoma
[4] along with thalamotomy for essential tremor [5] and
blood-brain barrier manipulation for chemotherapy [6].
Palliative treatment of bone metastases has been Food
and Drug Administration (FDA) approved since 2012
and offers a safe and effective noninvasive treatment op-
tion for metastatic bone pain, with more than 70 % of
patients experiencing fast pain reduction within 3 days
after treatment [2, 7, 8]. While the current treatment
goal is pain control through periosteal nerve ablation,
local tumor control has increasingly become of interest
as a primary treatment option [9, 10]. Recent studies
have shown that aggressive treatment (increased
temperature and duration) is promising for local tumor
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control [9]. In addition to palliation of painful bone me-
tastases, treatment of osteoid osteomas [11, 12] and
facetogenic back pain [13] has also shown significant
promise in early clinical studies.
Proton resonant frequency (PRF) shift thermometry is
the standard method for monitoring temperature during
MRgFUS interventions [14]. It can precisely measure the
changes in temperature in water-based tissues, but fails
to detect temperature changes in bone and in tissues
with high lipid content, such as bone marrow. In water,
the dependence of the PRF on temperature is attributed
to changes in the hydrogen bonds, which are absent in
fat [15]. Therefore, current clinical protocols rely on the
measurement of temperature change of the adjacent
muscle to estimate the temperature of the bone. This ap-
proach carries a significant risk of overtreatment in that
more energy might be used than is needed to ablate
bone. In fact, we observed in focused ultrasound (FUS)
treatments of bone metastases, that the highest
temperature in soft tissue was only reached 10–15 s after
the ultrasound (US) was switched off [16]. Collateral
treatment of the near-field soft tissues during MRgFUS
increases the risk for muscle and vascular injury, which
can result in significant perioperative or chronic pain.
For local control of osseous lesions, it is often benefi-
cial to achieve deeper penetration of the ablation
through the cortical bone into the bone marrow or
tumor. In the treatment of osteoid osteomas, complete
ablation of the nidus is required for sustained pain relief,
but the thickened cortical bone around the nidus makes
ultrasound penetration difficult. For such applications,
temperature measurement within the bone is critical to
reduce the risk of recurrence.
Direct temperature assessment in the bone using MRI
has been recently achieved using short and ultrashort
echo time (UTE) pulse sequences. Han et al. proposed
the use of UTE for quantifying the temperature change
in the cortical bone by measuring T1 changes [17]. Ram-
say et al. showed a temperature-dependent change in the
signal magnitude of the cortical bone at short echo time
(1 ms) [18]. However, the applications of these tech-
niques for in vivo monitoring of focused ultrasound
therapy are primarily hampered by signal-to-noise ratio
(SNR) constraints as well as long acquisition times.
Another way to quantify the effects of heating within
the bone would be to measure the temperature in bone
marrow. Red bone marrow contains blood forming cells
and fat (20–80 % by volume) and is found in flat bones
as well as in the trabecular (cancellous) tissue at the epi-
physeal ends of long bones [19]. Yellow marrow mainly
consists of fat cells (more than 80 % fat by volume) and
is found in the medullary cavity of long bones. Relax-
ation times of red bone marrow have been measured by
Schick et al. [20]. Previous studies have shown that a
change in T2 can be used to measure the temperature
change in other fatty tissues such as subcutaneous fat
and breast tissue [21–23]. Heijman et al. have demon-
strated the feasibility of T2-based MR thermometry in
extracted samples of yellow and red bone marrow [24],
but the lack of calibration data for bone marrow at 3T
made it difficult to convert T2 values into maps of tissue
temperature.
The goal of this study was to determine if T2-based
thermometry could be used to monitor the temperature
change in ex vivo and in vivo bone marrow during fo-
cused ultrasound ablation of bone lesions. We investi-
gated the dependence of T2 on temperature in ex vivo
bovine yellow bone marrow at thermal equilibrium at
3T and studied the influence of acquisition parameters
on the T2 measurements. We also examined if T2
changes in red bone marrow caused by the ablation of
ex vivo trabecular bone were reversible and measured
the patterns of heating and tissue damage. Finally, we
validated the technique during the ablation of intact ex
vivo bone samples and during an in vivo animal
experiment.
Methods
Yellow bone marrow temperature calibration
Bovine yellow bone marrow was extracted from the me-
dullary cavity of a femur segment, filled into a petri dish,
and placed in an insulated cylindrical container. The
container was filled with deionized water, which was cir-
culated by a peristaltic pump (Masterflex, Cole Parmer,
Vernon Hills, IL) through a heat exchanger. The heat ex-
changer was placed in a temperature-regulated water
bath (Polystat R6L, Cole-Parmer) set to the desired
temperature. To reduce heat loss from the heat exchan-
ger in the water bath outside the scanner room to the
sample container in the scanner bore, all tubes were
covered with pipe insulation. The temperature in the
water-filled container was monitored with a fiber optic
sensor (Luxtron, LumaSense Technologies, Santa Clara,
CA). The time necessary for temperature equilibration
within the sample has been determined previously [23]
by measuring the time it took to reach equilibrium after
a 10 °C change in circulating water temperature which
was found to be approximately 20 min.
T2 measurements were performed in a 3T MRI scan-
ner (MR750W, GE Healthcare, Waukesha, WI) using a
double-echo fast spin-echo (FSE) sequence with and
without water suppression (echo time (TE) = 35/182 ms
and 28/147 ms, repetition time (TR) = 1500 ms, echo
train length (ETL) = 40, field of view (FOV) = 12 cm,
128 × 128 matrix size, 8-mm slice thickness, 15 s acqui-
sition time). Water suppression was achieved via a fre-
quency selective pulse centered on the water frequency.
To ensure consistency, the frequency of the fat peak was
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verified before each scan, and the same pre-scan param-
eter values were used throughout the experiment. Im-
ages were acquired during heating (25, 35, 45, 55, 65,
and 70 °C) and subsequent cooling (55, 35, and 25 °C)
after reaching thermal equilibrium. T2 maps were gener-
ated with an exponential fit for two data points.
Trabecular bone marrow ablation
Two ex vivo experiments were performed on epiphysis
segments of bovine femur with a birdcage head coil (GE
Healthcare) at 3T. The samples were cut to expose the
trabecular tissue containing red marrow to the ultra-
sound beam. Three fiber optic sensors were placed into
drilled holes within the red marrow. The femoral seg-
ments were sonicated with the conformal bone focused
ultrasound system (ExAblate 2100, InSightec, Israel) op-
erating at 500 kHz, acoustic power of 17.6 W, and a
sonication time of 8 min, with the focus placed within
the bone marrow. T2 was quantified by using the
double-echo FSE sequence with water suppression de-
scribed above (TE = 35/181 ms, TR = 723 ms, echo train
length = 40, FOV = 24 cm, 128 × 128 matrix size, 10-mm
slice thickness, 15 s/slice). Images were acquired during
heating and cooling and after the sample reached room
temperature. T2 values were measured within three el-
liptical regions of interest (ROIs) (area: 8.6 mm2) placed
over the locations of the tips of the fiber optic sensors.
Intact cortical bone ablation
In order to test T2-based temperature monitoring in
conditions more closely resembling those of a bone
treatment, we performed ablation in an intact ex vivo
porcine femur (sonication time: 20 s, acoustic power:
30 W) using the in-table transducer of the ExAblate sys-
tem, operating at 1.15 MHz. The focus of the sonication
was placed within the yellow marrow of the diaphysis of
the femur with the ultrasound beam path intersecting
the cortical bone. Bone marrow T2 was quantified with
a double-echo FSE sequence with water suppression
(TE = 35/186 ms, TR = 1500 ms, echo train length = 40,
FOV = 32 cm, 128 × 128 matrix size, 10-mm slice thick-
ness, 15 s/slice).
In vivo temperature monitoring
Focused ultrasound ablation was also performed in a
swine model. All experimental procedures were done in
accordance with National Institutes of Health (NIH)
guidelines for humane handling of animals and received
prior approval from the University of California San
Francisco Institutional Animal Care and Use Committee
(approval number: AN088193). The animal was posi-
tioned in the left decubitus position onto a gel pad over
the ExAblate in-table transducer (Fig. 1) using a fre-
quency of 1 MHz. A total of 12 sonications were
performed on the distal diaphysis (six sonications, 35 W,
20 s) and proximal diaphysis (six sonications, 17 W,
40 s) of the femur. As in the ex vivo validation, the focus
was placed inside the medullary cavity. At the end of the
focused ultrasound procedure, pre- and post-contrast
3D fast spoiled gradient echo (SPGR) images were
acquired.
Results
Yellow bone marrow temperature calibration
Figure 2 shows examples of T2 maps of ex vivo bone mar-
row at 25 and 70 °C acquired with TE = 35/182 ms and
water suppression. The T2 values within a 10 × 10 pixel
ROI (black square on Fig. 2a) versus the temperature of
the water bath at equilibrium are plotted in Fig. 2d. The
linear regression line of the data acquired during heating
exhibited a steeper slope than that of the cooling phase.
Table 1 shows the linear regression coefficients of T2
versus temperature for the different acquisition parame-
ters. There was approximately a 25 % difference between
the measurements with and without water suppression.
The difference in the T2/temperature coefficients be-
tween the two sets of echo times was smaller.
Trabecular bone marrow ablation
Figure 3 shows the T2 change during heating and cool-
ing of a sample of trabecular bone marrow. As can be
seen, despite the focal spot being deep within trabecular
bone, most of the energy was absorbed at the edge of
the sample and then radiated into the marrow.
Figure 4 shows a plot of T2 change versus the temper-
atures over time, measured by the three fiber optic
probes. There was a linear relationship (5.7 ms per °C)
during the heating stage of the experiment (red points).
The T2 change during cooling (blue) showed a reduction
with temperature, but did not follow the same linearity
as during heating.
Figure 5 shows the T2 change of another bone seg-
ment during heating (a) and after it returned to room
temperature (b). The profiles through the heated region
(Fig. 5c, d) show residual T2 elevation of about 35 ms in
the ablated area suggesting irreversible tissue changes.
The area of residual T2 elevation after cooldown
matched the area of the heating.
Intact cortical bone ablation
Figure 6 shows the results of the ex vivo experiment,
where we measured a T2 elevation of 269 ms. We ob-
served an increase in T2 values in the area of the mar-
row adjacent to the intersection of the cortical bone and
the beam path. Assuming a linear coefficient of 7 ms/°C
from the yellow marrow calibration experiment, this cor-
responded to a temperature rise of 38 °C. The ex vivo
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Fig. 1 Planning image of one of the sonications in a swine model with the path of the US beam overlaid in blue, the focal point as a yellow cross,
and the area of expected thermal dose as a yellow outline
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Fig. 2 FSE images of a petri dish (no water suppression), containing bovine yellow bone marrow within the insulated water bath (a); T2 maps
of the sample at 25 °C (b); and at 70 °C (c); plot of T2 versus temperature for ex vivo bone marrow during heating (red) and cooling (blue)
(d) acquired with TE = 35/182 and water suppression
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experiment showed that it took on the order of 15 min
for the marrow to return to baseline temperature.
In vivo temperature monitoring
Figure 7 shows the results of one of the sonications of
the in vivo experiment in a swine model. An area of ele-
vated T2 values in the marrow, adjacent to the cortical
bone in the US beam path appeared on the T2 maps ac-
quired during heating (Fig. 7a). From the plot of the T2
values within an ROI over time (Fig. 7c), we observed
that the highest T2 values appeared at the end of the
sonication. We measured a T2 rise of 231 ms within the
bone marrow, which corresponded to temperature
change of 33 °C from baseline according to the data
from the calibration experiment. The in vivo experiment
showed excellent correspondence between the area of
T2 elevation in marrow during the ablation and the
resulting non-enhancing area in the post-contrast images
(Fig. 7b).
Discussion
In this study, we have measured the temperature de-
pendency of T2 in yellow and red bone marrow, devel-
oped T2-based thermometry for monitoring of MRgFUS
ablation of trabecular and cortical bone, and validated
the technique in an animal experiment.
First, we have calibrated the temperature dependence
of T2 in yellow bone marrow for temperatures between
25 and 70 °C at 3T. We found that sequence parameters
influence the relationship between the measured T2
Table 1 Linear regression coefficients of T2 versus temperature
(ms/°C) for the different pulse sequence parameters
Heating Cooling
Water Suppr. TE = 28/147 7.05 5.39
Water Suppr. TE = 35/182 7.00 5.39
No Water Suppr. TE = 35/182 5.48 4.47
0 100 200 300 ms
Heating On
Heating Off
a b
Fig. 3 a Magnitude image acquired during sonication showing the setup for T2-based thermometry of trabecular bone marrow during focused
ultrasound sonications showing the fiber optic probes; b T2 maps of sample 1 during heating and cool-down
0 10 20 30 40 50 60
0
50
100
150
200
250
300
350
Temperature Change (Celcius,Deg)
T
2 
ch
an
ge
 (
m
s)
Sensor 1
Sensor 2
Sensor 3
Fig. 4 Temperature change, measured by three probes within the
bone marrow sample and T2 change at the same locations during
heating (red) and cooling (blue)
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values and temperature. In particular, there was a large
difference between the measurements with and without
water suppression. Although yellow marrow mainly con-
sists of fat cells, there could still be a contribution of
water spins to the measured T2 in the non-water-
suppressed acquisitions or a portion of the fat spins
could be suppressed in the water-suppressed acquisition.
Changing the echo times had less effect on the measured
values. In order to achieve high temperature accuracy,
the calibration of T2-based thermometry techniques
should be done with the same parameters as those used
for temperature monitoring during the treatment of pa-
tients. To maintain consistency despite varying concen-
tration of water in the marrow, water suppression
should be used for T2-based thermometry of fatty tis-
sues and was employed in the rest of the experiments
presented here.
In the experiments in ex vivo trabecular and cortical
bone, we observed that even though the focal points
were placed in the middle of the bone, due to the high
ultrasound absorption of bone, most of the energy was
absorbed at its edge. The trabecular bone ablation exper-
iments, where heating continued for 8 min, showed that
there was a residual change of T2 values in the area of
the marrow that experienced heating even after the sam-
ple returned to the room temperature. This was consist-
ent with the results of our calibration experiments in
yellow and red marrow, where T2 values followed a
more gradual slope on the cooldown from high tempera-
tures then the values observed during heating. Similar
effect has been previously observed in subcutaneous fat
after exposure to high temperatures [23]. Elevated T2
values in the areas of thermal damage could be an indi-
cator of irreversible tissue changes and allow for evalu-
ation of treatment effects during bone MRgFUS therapy.
We did not observe residual T2 changes in the marrow
of the ex vivo or in vivo cortical bone ablation. Either
the shorter sonication duration did not cause irreversible
400
100
200
300
ms
100
ms
0 100 200 300
ms
a c
d
b
0 20 40mm
40
60
80
Fig. 5 T2 maps of sample 2: a during heating; b after reaching
room temperature; c T2 profile of the sample along the line, shown
in a; d T2 profile along the line, shown in b
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Fig. 6 T2 measurement in ex vivo bone marrow during and after the heating. a Localizer image showing the ultrasound transducer in the table.
b T2 map during heating, showing the ROI. c Plot of T2 values within the ROI over time
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changes or changes were not apparent due to lower
spatial resolution.
In our animal experiment, we observed a T2 increase in
the marrow of 231 ms from the baseline value of approxi-
mately 200 ms during heating. Baseline values in the ex
vivo samples were much lower due to the difference in ini-
tial temperature. The area of elevated T2 in the marrow
matched the non-perfused volume in the post-contrast
images. The highest temperature in the marrow was
achieved very close to the end of the sonication. This is
contrary to PRF measurements in muscle adjacent to the
cortical bone, where the maximum temperature is reached
10–15 s after the end of the sonication [16]. This suggests
that temperature in marrow could be a more direct meas-
ure of bone heating than the temperature in surrounding
muscle tissues. Monitoring temperature in marrow could
reduce the risk of overtreatment due to underestimation
of the temperature of the bone.
As a proof of concept work, this study had several lim-
itations. The T2-based thermometry technique was per-
formed in a very small number of samples and animals
to date. Future work is needed to validate the technique
in a larger population. For the ex vivo experiments, we
used previously refrigerated samples. There may be a
difference between T2/temperature coefficients between
refrigerated, freshly excised, and in vivo tissue, as well as
between bovine, porcine, and human bone marrow. In
vivo and ex vivo cortical bone ablation experiments re-
lied on the previously estimated calibration coefficients,
since it would be very difficult to embed temperature
sensors in those samples and animals, and precisely
register the sensor tip to the corresponding voxel in an
area of large temperature gradients. In our calibration
experiments we used yellow marrow, which was ex-
tracted from the medullary cavity. In humans or animals,
the medullary cavity may contain either yellow, red, or,
not uncommonly, a blend of both types of marrow. The
effect of the marrow composition on the temperature co-
efficient remains to be investigated. The T2/temperature
calibration in this work has been performed at 3T. The
coefficient is likely dependent on field strength and should
be calibrated with the same acquisition parameters that
would be used in vivo.
The technique itself has several limitations at this
stage. Achieving consistent water suppression was diffi-
cult since we used frequency selective suppression,
T
2,
 m
s
time, min
heating: 40 s
0 0.5 1 1.5 2 2.5
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450
0
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250
300
350
400
a b
c
T
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Fig. 7 T2 measurement in in vivo bone marrow: a T2 map during ablation of a single sonication, showing the ROI; b post-contrast 3D Fast SPGR
image after ablation (total of six sonications per location); c plot of T2 values within the ROI over time; the highlighted area shows the approxi-
mate duration of the sonication
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which was very sensitive to pre-scan parameters, as well
as B0 and B1 inhomogeneities. Other techniques such as
spectral spatial excitation and inversion recovery could
be considered for suppression of the water signal. It is
currently not possible to simultaneously acquire both
T2-based thermometry in the marrow and PRF-based
thermometry in the surrounding muscle, since those
techniques use different pulse sequences. This could be
accomplished with interleaved acquisition techniques
[25]. The technique described here supported a single
slice imaging with 15 s acquisition time. Accelerated
k-space readout trajectories, such as echo-planar or spiral,
could improve spatial coverage and temporal resolution of
the technique.
Conclusions
We have shown that T2-based ablation monitoring in
red and yellow bone marrow is feasible. Our results were
consistent with previously published data in marrow and
subcutaneous fat. The linear relationship between T2
change and temperature could be used to quantify the
temperature during heating of up to 60 °C. This would
allow to reliably and accurately monitor the temperature
inside the trabecular bone during treatment of patients
with bone tumors. The ability to monitor the
temperature within the bone marrow allowed more
complete visualization of the heat distribution into the
bone, which is important for local lesion control and
treatment of osteoid osteomas. Therefore, T2-based
temperature mapping, in addition to PRF-based therm-
ometry, could be used to monitor heating during the
bone focused ultrasound treatments and improve safety
and efficacy of MRgFUS bone applications.
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